O	0	11	Feasibility
O	12	15	and
O	16	23	effects
O	24	26	of
O	27	28	a
O	29	37	combined
O	38	46	adjuvant
B-intervention	47	51	high
I-intervention	51	52	-
I-intervention	52	61	intensity
I-intervention	62	70	interval
I-intervention	70	71	/
I-intervention	71	79	strength
I-intervention	80	88	training
O	89	91	in
O	92	98	breast
O	99	105	cancer
O	106	114	patients
O	114	115	:
O	116	117	a
O	118	124	single
O	124	125	-
O	125	131	center
O	132	137	pilot
O	138	143	study
O	143	144	.

O	145	147	To
O	148	156	evaluate
O	157	168	feasibility
O	169	171	of
O	172	174	an
O	175	183	exercise
O	184	196	intervention
O	197	207	consisting
O	208	210	of
O	211	215	high
O	215	216	-
O	216	225	intensity
O	226	234	interval
O	235	244	endurance
O	245	248	and
O	249	257	strength
O	258	266	training
O	267	269	in
O	270	276	breast
O	277	283	cancer
O	284	292	patients
O	292	293	.

B-total-participants	294	300	Twenty
I-total-participants	300	301	-
I-total-participants	301	304	six
B-eligibility	305	310	women
I-eligibility	311	315	with
I-eligibility	316	329	nonmetastatic
I-eligibility	330	336	breast
I-eligibility	337	343	cancer
O	344	348	were
O	349	362	consecutively
O	363	371	assigned
O	372	374	to
O	375	378	the
O	379	387	exercise
O	388	400	intervention
O	400	401	-
O	402	403	(
O	403	404	n
O	404	405	=
B-intervention-participants	406	408	15
O	408	409	,
O	410	414	mean
O	415	418	age
B-age	419	421	51
I-age	421	422	.
I-age	422	423	9
I-age	424	425	±
I-age	426	427	9
I-age	427	428	.
I-age	428	429	8
I-age	430	435	years
O	435	436	)
O	437	440	and
O	441	444	the
B-control	445	452	control
I-control	453	458	group
O	459	460	(
O	460	461	n
O	462	463	=
B-control-participants	464	466	11
O	466	467	,
O	468	472	mean
O	473	476	age
B-age	477	479	56
I-age	479	480	.
I-age	480	481	9
I-age	482	483	±
I-age	484	485	7
I-age	485	486	.
I-age	486	487	0
I-age	488	493	years
O	493	494	)
O	494	495	.

O	496	511	Cardiopulmonary
O	512	520	exercise
O	521	528	testing
O	529	533	that
O	534	542	included
O	543	550	lactate
O	551	559	sampling
O	559	560	,
O	561	564	one
O	564	565	-
O	565	575	repetition
O	576	583	maximum
O	584	589	tests
O	590	593	and
O	594	595	a
O	596	600	HADS
O	600	601	-
O	601	602	D
O	603	616	questionnaire
O	617	621	were
O	622	626	used
O	627	629	to
O	630	637	monitor
O	638	646	patients
O	647	651	both
O	652	658	before
O	659	662	and
O	663	668	after
O	669	670	a
O	671	681	supervised
O	682	685	six
O	686	691	weeks
O	692	698	period
O	699	701	of
O	702	708	either
O	709	717	combined
O	718	722	high
O	722	723	-
O	723	732	intensity
O	733	741	interval
O	742	751	endurance
O	752	755	and
O	756	764	strength
O	765	773	training
O	774	775	(
O	775	787	intervention
O	788	793	group
O	793	794	,
O	795	800	twice
O	801	802	a
O	803	807	week
O	807	808	)
O	809	811	or
O	812	819	leisure
O	820	828	training
O	829	830	(
O	830	837	control
O	838	843	group
O	843	844	)
O	844	845	.

O	846	856	Contrarily
O	857	859	to
O	860	863	the
O	864	871	control
O	872	877	group
O	877	878	,
B-outcome	879	888	endurance
O	889	890	(
O	890	894	mean
O	895	901	change
O	902	904	of
O	905	908	VO2
O	908	909	,
O	910	914	peak
O	915	917	12
O	917	918	.
O	918	919	0
O	920	921	±
O	922	924	13
O	924	925	.
O	925	926	0
O	926	927	%
O	927	928	)
O	929	932	and
B-outcome	933	941	strength
I-outcome	942	953	performance
O	954	955	(
O	955	959	mean
O	960	966	change
O	967	969	of
O	970	980	cumulative
O	981	985	load
O	986	988	25
O	988	989	.
O	989	990	9
O	991	992	±
O	993	995	11
O	995	996	.
O	996	997	2
O	997	998	%
O	998	999	)
O	1000	1003	and
B-outcome	1004	1011	quality
I-outcome	1012	1014	of
I-outcome	1015	1019	life
O	1020	1029	increased
O	1030	1032	in
O	1033	1036	the
O	1037	1049	intervention
O	1050	1055	group
O	1055	1056	.

O	1057	1059	No
O	1060	1068	training
O	1068	1069	-
O	1069	1076	related
B-outcome	1077	1084	adverse
I-outcome	1085	1091	events
O	1092	1096	were
O	1097	1105	observed
O	1105	1106	.

O	1107	1110	Our
O	1111	1117	guided
O	1118	1126	exercise
O	1127	1139	intervention
O	1140	1145	could
O	1146	1148	be
O	1149	1153	used
O	1154	1165	effectively
O	1166	1169	for
O	1170	1180	initiation
O	1181	1184	and
O	1185	1196	improvement
O	1197	1199	of
O	1200	1211	performance
O	1212	1220	capacity
O	1221	1224	and
O	1225	1232	quality
O	1233	1235	of
O	1236	1240	life
O	1241	1243	in
O	1244	1250	breast
O	1251	1257	cancer
O	1258	1266	patients
O	1267	1269	in
O	1270	1271	a
O	1272	1282	relatively
O	1283	1288	short
O	1289	1293	time
O	1293	1294	.

O	1295	1299	This
O	1300	1305	might
O	1306	1308	be
O	1309	1319	especially
O	1320	1330	attractive
O	1331	1337	during
O	1338	1345	medical
O	1346	1355	treatment
O	1355	1356	.

O	1357	1361	Long
O	1361	1362	-
O	1362	1366	term
O	1367	1374	effects
O	1375	1379	have
O	1380	1382	to
O	1383	1385	be
O	1386	1395	evaluated
O	1396	1398	in
O	1399	1409	randomized
O	1410	1420	controlled
O	1421	1428	studies
O	1429	1433	also
O	1434	1438	with
O	1439	1440	a
O	1441	1447	longer
O	1448	1454	follow
O	1454	1455	-
O	1455	1457	up
O	1457	1458	.

O	1459	1471	Implications
O	1472	1475	for
O	1476	1490	Rehabilitation
O	1491	1495	High
O	1495	1496	-
O	1496	1505	intensity
O	1506	1514	interval
O	1515	1523	training
O	1524	1530	allows
O	1531	1542	improvement
O	1543	1545	of
O	1546	1553	aerobic
O	1554	1562	capacity
O	1563	1569	within
O	1570	1571	a
O	1572	1582	comparable
O	1583	1588	short
O	1589	1593	time
O	1593	1594	.

O	1595	1603	Standard
O	1604	1611	leisure
O	1612	1620	training
O	1621	1623	in
O	1624	1630	breast
O	1631	1637	cancer
O	1638	1646	patients
O	1647	1649	is
O	1650	1656	rather
O	1657	1665	suitable
O	1666	1669	for
O	1670	1673	the
O	1674	1685	maintenance
O	1686	1688	of
O	1689	1700	performance
O	1701	1709	capacity
O	1710	1713	and
O	1714	1721	quality
O	1722	1724	of
O	1725	1729	life
O	1729	1730	.

O	1731	1737	Guided
O	1738	1742	high
O	1742	1743	-
O	1743	1752	intensity
O	1753	1761	interval
O	1762	1770	training
O	1771	1779	combined
O	1780	1784	with
O	1785	1793	strength
O	1794	1802	training
O	1803	1806	can
O	1807	1809	be
O	1810	1814	used
O	1815	1826	effectively
O	1827	1830	for
O	1831	1834	the
O	1835	1846	improvement
O	1847	1849	of
O	1850	1859	endurance
O	1860	1863	and
O	1864	1872	strength
O	1873	1881	capacity
O	1882	1885	and
O	1886	1890	also
O	1891	1898	quality
O	1899	1901	of
O	1902	1906	life
O	1906	1907	.

O	1908	1913	After
O	1914	1923	exclusion
O	1924	1926	of
O	1927	1944	contraindications
O	1944	1945	,
O	1946	1952	guided
O	1953	1961	adjuvant
O	1962	1966	high
O	1966	1967	-
O	1967	1976	intensity
O	1977	1985	interval
O	1986	1994	training
O	1995	2003	combined
O	2004	2008	with
O	2009	2017	strength
O	2018	2026	training
O	2027	2030	can
O	2031	2033	be
O	2034	2040	safely
O	2041	2045	used
O	2046	2048	in
O	2049	2055	breast
O	2056	2062	cancer
O	2063	2071	patients
O	2071	2072	.
